How Should Pathology Findings Influence Treatment in IgA Nephropathy?
作者信息
Troyanov Stéphan, Hladunewich Michelle A, Reich Heather N
机构信息
Division of Nephrology, Department of Medicine, Hôpital du Sacré-Coeur de Montréal, University of Montreal, Montreal, Quebec, Canada.
Division of Nephrology, Department of Medicine, Sunnybrook Health Science Center, University of Toronto, Toronto, Ontario, Canada.
出版信息
Kidney Int Rep. 2021 Nov 20;7(1):3-5. doi: 10.1016/j.ekir.2021.11.001. eCollection 2022 Jan.
Abstract
摘要
相似文献
1
How Should Pathology Findings Influence Treatment in IgA Nephropathy?病理检查结果应如何影响IgA肾病的治疗？
Kidney Int Rep. 2021 Nov 20;7(1):3-5. doi: 10.1016/j.ekir.2021.11.001. eCollection 2022 Jan.
2
Complement activation in IgA nephropathy.补体激活在 IgA 肾病中的作用。
Semin Immunopathol. 2021 Oct;43(5):679-690. doi: 10.1007/s00281-021-00882-9. Epub 2021 Aug 11.
3
Does Bi-Exponential Fitting Perform Better than Mono-Exponential Fitting in IVIM-DWI? An Assessment of Renal Pathological Injury of IgA Nephropathy.在体素内不相干运动扩散加权成像（IVIM-DWI）中，双指数拟合比单指数拟合表现更好吗？IgA肾病肾病理损伤的评估
Curr Med Imaging. 2023 Jun 27. doi: 10.2174/1573405620666230627103919.
4
[Regulatory effect of Astragalus membranaceus on the immune disorder in rats with IgA nephropathy].黄芪对IgA肾病大鼠免疫紊乱的调节作用
Zhonghua Er Ke Za Zhi. 2008 Jan;46(1):55-60.
5
IgA nephropathy with minimal change disease.IgA 肾病伴微小病变病。
Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1033-9. doi: 10.2215/CJN.11951113. Epub 2014 Apr 10.
6
[Results of a survey of the relationship between palatine tonsil and IgA nephropathy].[腭扁桃体与IgA肾病关系的调查结果]
Nihon Jibiinkoka Gakkai Kaiho. 1999 Mar;102(3):305-10. doi: 10.3950/jibiinkoka.102.305.
7
IgA Nephropathy and Atypical Anti-GBM Disease: A Rare Dual Pathology in a Pediatric Rapidly Progressive Glomerulonephritis.IgA肾病与非典型抗肾小球基底膜病：小儿急进性肾小球肾炎中的一种罕见双重病理情况
Glomerular Dis. 2021 Dec 20;2(1):54-57. doi: 10.1159/000521582. eCollection 2022 Jan.
8
IgA nephropathy: "State of the art": a report from the 15th International Symposium on IgA Nephropathy celebrating the 50th anniversary of its first description.IgA 肾病：“最新进展”：第 15 届国际 IgA 肾病研讨会上的报告，该会议庆祝了其首次描述的 50 周年。
Kidney Int. 2019 Apr;95(4):750-756. doi: 10.1016/j.kint.2019.01.007.
9
Immunoglobulin A nephropathy and chronic kidney disease.免疫球蛋白 A 肾病与慢性肾脏病。
Nephrology (Carlton). 2010 Jun;15 Suppl 2:23-6. doi: 10.1111/j.1440-1797.2010.01307.x.
10
Correlation of serum levels of complement C4a desArg with pathologically estimated severity of glomerular lesions and mesangial hypercellularity scores in patients with IgA nephropathy.血清补体 C4a desArg 水平与 IgA 肾病患者肾小球病变和系膜细胞增生评分的病理估计严重程度的相关性。
Int J Mol Med. 2013 Aug;32(2):307-14. doi: 10.3892/ijmm.2013.1390. Epub 2013 May 24.
引用本文的文献
1
Long-term evaluation of the timing of corticosteroid therapy in an IgA nephropathy cohort.IgA肾病队列中皮质类固醇治疗时机的长期评估。
Clin Kidney J. 2025 Mar 17;18(5):sfaf076. doi: 10.1093/ckj/sfaf076. eCollection 2025 May.
2
Characteristics of renal pathology and coagulation function in IgA nephropathy and IgA vasculitis associated nephritis.IgA肾病和IgA血管炎相关性肾炎的肾脏病理及凝血功能特征
BMC Nephrol. 2024 Jan 25;25(1):35. doi: 10.1186/s12882-024-03465-6.
3
The predictive value and response to immunosuppressive therapy of IgA nephropathy patients with crescents in a large retrospective Chinese cohort.中国一个大型回顾性队列中伴有新月体的IgA肾病患者的预测价值及对免疫抑制治疗的反应
Clin Kidney J. 2023 Jun 7;16(12):2417-2428. doi: 10.1093/ckj/sfad134. eCollection 2023 Dec.
4
[Diagnosis and Treatment of IgA Nephropathy-2023].[2023年IgA肾病的诊断与治疗]
Wien Klin Wochenschr. 2023 Aug;135(Suppl 5):621-627. doi: 10.1007/s00508-023-02257-6. Epub 2023 Sep 20.
本文引用的文献
1
A Novel Scoring System Based on Oxford Classification Indicating Steroid Therapy Use for IgA Nephropathy.一种基于牛津分类法的新型评分系统，用于指导IgA肾病的类固醇治疗。
Kidney Int Rep. 2021 Oct 14;7(1):99-107. doi: 10.1016/j.ekir.2021.10.007. eCollection 2022 Jan.
2
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases.KDIGO 2021肾小球疾病管理临床实践指南。
Kidney Int. 2021 Oct;100(4S):S1-S276. doi: 10.1016/j.kint.2021.05.021.
3
Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort.IgA 肾病牛津分类的可重复性、活检评分对治疗分配的影响以及分歧的临床意义：来自 VALIDATION 研究队列的证据。
Nephrol Dial Transplant. 2019 Oct 1;34(10):1681-1690. doi: 10.1093/ndt/gfy337.
4
Renal outcomes of STOP-IgAN trial patients in relation to baseline histology (MEST-C scores).STOP-IgAN 试验患者的肾脏结局与基线组织学（MEST-C 评分）的关系。
BMC Nephrol. 2018 Nov 19;19(1):328. doi: 10.1186/s12882-018-1128-6.
5
Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices.狼疮肾炎国际肾脏病学会/肾脏病理学会分类修订：定义的澄清，以及国立卫生研究院活动和慢性指数的修改。
Kidney Int. 2018 Apr;93(4):789-796. doi: 10.1016/j.kint.2017.11.023. Epub 2018 Feb 16.
6
Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.口服甲泼尼龙对IgA肾病患者临床结局的影响：TESTING随机临床试验
JAMA. 2017 Aug 1;318(5):432-442. doi: 10.1001/jama.2017.9362.
7
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.牛津 IgA 肾病分类 2016 年更新：IgA 肾病分类工作组的报告。
Kidney Int. 2017 May;91(5):1014-1021. doi: 10.1016/j.kint.2017.02.003. Epub 2017 Mar 22.
8
Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy.牛津分类队列研究的证据支持 IgA 肾病局灶节段性肾小球硬化的亚分类在临床上的价值。
Kidney Int. 2017 Jan;91(1):235-243. doi: 10.1016/j.kint.2016.09.029. Epub 2016 Dec 1.
9
The MEST score provides earlier risk prediction in lgA nephropathy.MEST 评分可更早预测 IgA 肾病的风险。
Kidney Int. 2016 Jan;89(1):167-75. doi: 10.1038/ki.2015.322.
10
Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.泼尼松与血管紧张素转换酶抑制剂联合治疗对比单独使用血管紧张素转换酶抑制剂治疗IgA肾病患者：一项随机对照试验
Am J Kidney Dis. 2009 Jan;53(1):26-32. doi: 10.1053/j.ajkd.2008.07.029. Epub 2008 Oct 19.
Zotero 插件